全文获取类型
收费全文 | 1704篇 |
免费 | 154篇 |
国内免费 | 20篇 |
专业分类
耳鼻咽喉 | 17篇 |
儿科学 | 90篇 |
妇产科学 | 9篇 |
基础医学 | 193篇 |
口腔科学 | 65篇 |
临床医学 | 151篇 |
内科学 | 285篇 |
皮肤病学 | 53篇 |
神经病学 | 54篇 |
特种医学 | 243篇 |
外科学 | 483篇 |
综合类 | 32篇 |
一般理论 | 1篇 |
预防医学 | 66篇 |
眼科学 | 19篇 |
药学 | 49篇 |
1篇 | |
肿瘤学 | 67篇 |
出版年
2023年 | 5篇 |
2022年 | 4篇 |
2021年 | 15篇 |
2020年 | 17篇 |
2019年 | 26篇 |
2018年 | 33篇 |
2017年 | 18篇 |
2016年 | 24篇 |
2015年 | 37篇 |
2014年 | 37篇 |
2013年 | 63篇 |
2012年 | 48篇 |
2011年 | 55篇 |
2010年 | 78篇 |
2009年 | 81篇 |
2008年 | 49篇 |
2007年 | 63篇 |
2006年 | 53篇 |
2005年 | 50篇 |
2004年 | 40篇 |
2003年 | 54篇 |
2002年 | 39篇 |
2001年 | 51篇 |
2000年 | 29篇 |
1999年 | 52篇 |
1998年 | 90篇 |
1997年 | 89篇 |
1996年 | 65篇 |
1995年 | 56篇 |
1994年 | 42篇 |
1993年 | 45篇 |
1992年 | 28篇 |
1991年 | 39篇 |
1990年 | 37篇 |
1989年 | 50篇 |
1988年 | 43篇 |
1987年 | 30篇 |
1986年 | 23篇 |
1985年 | 22篇 |
1984年 | 11篇 |
1983年 | 15篇 |
1982年 | 16篇 |
1981年 | 14篇 |
1980年 | 18篇 |
1979年 | 14篇 |
1978年 | 21篇 |
1977年 | 28篇 |
1976年 | 19篇 |
1975年 | 11篇 |
1934年 | 3篇 |
排序方式: 共有1878条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
D De AJ Kanwar S Handa 《Journal of the European Academy of Dermatology and Venereology》2006,20(7):853-859
BACKGROUND: Diagnosis of atopic dermatitis (AD) depends on clinical features because no definitive diagnostic test exists. Criteria proposed by Hanifin and Rajka (Acta Derm Venereol (Stockh) 1980; Suppl 92: 44-47) were acceptable for hospital-based studies but were found not to be suitable for field studies. A UK working party formulated clinical diagnostic criteria that could be used in both hospital and epidemiological settings. Validation studies of the criteria showed widely variable results, probably due to different clinical settings and ethnicity. AIM AND OBJECTIVE: This study was undertaken to validate Hanifin and Rajka's criteria and to assess the comparative efficacy of their criteria and the UK working party's diagnostic criteria in the diagnosis of AD in a hospital setting in North India. SUBJECTS AND METHODS: This study serially included 101 patients with AD and 48 controls of paediatric age group. The study period was from July 2003 to December 2004. RESULTS: Hanifin and Rajka's criteria (sensitivity 96%, specificity 93.75%, positive predictive value 97% (PPV) and negative predictive value (NPV) 91.84%) had a statistical advantage over the UK working party's diagnostic criteria (sensitivity 86%, specificity 95.83%, PPV 97.75% and NPV 76.67%), with a P-value < 0.005. 相似文献
5.
R Schlumpf P Morel J J Loveras R M Condie A Matas J Kurle J S Najarian D E Sutherland 《Transplantation proceedings》1991,23(5):2362-2365
The delayed contralateral nephrectomy procedure (three-step) produced inconsistent results, indicating that the preserved autotransplanted kidney tends to remain unfunctional and to regenerate incompletely unless the demand for work is placed upon it. Omission of HES in UW (UW-plain) did not affect preservation success, but resulted in increased graft edema. Substitution of HES in UW with plasma (SGF-V) or albumin (MAlb) gave significantly worse results than UW-like solutions with or without synthetic colloids. Replacement of HES in UW with UMdex-70 or UMdex-500 gave nonsignificantly worse results than UW-like solutions with or without synthetic colloids. The use of UMdex-40 as the main colloid in UW cheapened the solution, equalled the preservation success of UW and UW-plain but surpassed UW-plain in edema prevention, and exceeded UW concerning recovery of graft microcirculation. 相似文献
6.
Recurrence of disease in patients retransplanted for focal segmental glomerulosclerosis. 总被引:6,自引:0,他引:6
E Stephanian A J Matas S M Mauer B Chavers T Nevins C Kashtan D E Sutherland P Gores J S Najarian 《Transplantation》1992,53(4):755-757
The natural history of focal segmental glomerulosclerosis in patients retransplanted after loss of a primary allograft is not well established. We studied 14 patients with FSGS who were retransplanted between April 1964 and September 1990 to determine if recurrence in a second or subsequent allograft could be predicted. In this group, 8 of the primary allografts were lost to recurrent disease and 6 to rejection. None of the 6 patients who lost their primary allograft to rejection without evidence of recurrent FSGS suffered recurrent disease after retransplantation. In contrast, 3 of the 8 patients who lost their primary allograft rapidly to FSGS suffered recurrent disease and loss of function in all subsequent allografts. The remaining 5 patients had prolonged function of the primary allograft ranging between 4 and 10.5 years, despite recurrence of FSGS. Of these 5 patients, 2 have excellent renal function after retransplantation without recurrence of FSGS in the secondary allograft at 9 and 10.5 years posttransplant; 2 have lost their secondary allograft to recurrent FSGS, but are free of recurrence in the third allograft at 0.5 and 5.8 years postoperatively; 1 maintains a serum creatinine level of 1.9 mg% despite recurrence of FSGS in the secondary allograft at 1 year postoperatively. Our data show that, without recurrence of FSGS in the primary allograft, further renal transplants will be free of recurrent disease. Based on this finding, we advocate use of living-related donors for second transplants in these patients. With rapid recurrence of FSGS and subsequent accelerated loss of the primary allograft, further renal transplants carry a high likelihood of recurrent FSGS and graft loss. A substantial proportion of patients with recurrent FSGS in the primary allograft will have prolonged renal function, and are likely to have excellent results with subsequent allografts. 相似文献
7.
Between 1/1/76 and 12/31/86, 448 patients underwent transplantation (360 first transplants). Of these, 286 (230 first) were referred by 5 dialysis centers, each referring more than 40 recipients. The remainder were referred by a large number of centers. Using our 5 largest referral centers, we studied the effect of dialysis center on graft and patient survival. There was no difference between dialysis centers in patient survival. Actuarial graft survival differed significantly for all cadaver transplants and for first cadaver transplants (P less than 105). Significant differences persisted when groups were subdivided by type of immunosuppression (azathioprine vs cyclosporine). Demographic (age, race, cause of renal disease) and immunologic (transfusions, PRA, matching) differences between groups did not explain the difference in graft survival. We conclude that referring dialysis center is a previously unrecognized factor affecting transplant outcome. Further studies with larger numbers will be required to determine the underlying reasons for ths phenomenon. 相似文献
8.
Kuntal Patel Deemesh Oudit G Ross Caroline Nicolson AJ Howcroft 《CANADIAN JOURNAL OF PLASTIC SURGERY》2005,13(4):207-208
A lump on the midface of a child can pose as a diagnostic dilemma. There is a wide variety of possible differential diagnoses, ranging from simple benign conditions such as a sebaceous cyst, dermoid cyst, lipoma, neuroma and neurofibroma, to potentially devastating conditions such as odontogenic myxoma.A case of a child in which the formulation of a definite diagnosis was clinically and histologically challenging is presented. 相似文献
9.
Arthur J. Matas Raja Kandaswamy Kristen J. Gillingham Lois McHugh Hassan Ibrahim Bertram Kasiske Abhinav Humar 《American journal of transplantation》2005,5(10):2473-2478
Concern persists that prednisone-free maintenance immunosuppression in kidney transplant recipients will be associated with an increase in late allograft dysfunction and graft loss. We herein report 5-year follow-up of a trial of prednisone-free maintenance immunosuppression. From October 1, 1999, through January 31, 2005, at our center, 589 kidney transplant recipients were treated with a protocol incorporating discontinuation of their prednisone on postoperative day 6. At 5 years, actuarial patient survival was 91%; graft survival, 84%; death-censored graft survival, 92%; acute rejection-free graft survival, 84% and chronic rejection-free graft survival, 87%. The mean serum creatinine level (+/-SD) at 1 year was 1.6 +/- 0.6; at 5 years, 1.7 +/- 0.8. In all, 86% of kidney recipients with functioning grafts remain prednisone-free as of April 30, 2005. As compared with historical controls, recipients on prednisone-free maintenance immunosuppression had a significantly lower rate of a number of complications, including cataracts (p < 0.001), posttransplant diabetes mellitus (p < 0.001), avascular necrosis (p = 0.001), and fractures (p = 0.004). We conclude that prednisone-related side effects can be minimized in a protocol incorporating prednisone-free maintenance immunosuppression. Five-year graft outcome remains good. 相似文献
10.